Workflow
傲农生物(603363) - 2025 Q1 - 季度业绩预告(更正)
603363Aonong Group(603363)2025-04-11 11:30

Financial Performance - The company expects a net profit attributable to shareholders of the parent company for Q1 2025 to be between 200 million and 300 million CNY, an increase of 492.02 million to 592.02 million CNY compared to the same period last year, indicating a turnaround from loss to profit [2]. - The estimated net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -35 million and -45 million CNY, a reduction in loss of 318.37 million to 328.37 million CNY compared to the same period last year [2]. - The total profit for the same period last year was -377.90 million CNY, with a net profit attributable to shareholders of the parent company at -292.02 million CNY [7]. Operational Improvements - The company achieved a significant reduction in operational burdens through bankruptcy restructuring, leading to a substantial decrease in debt scale and interest expenses [9]. - The rise in pig prices compared to the same period last year, along with a significant decrease in breeding costs, contributed to profitability in the breeding segment [9]. - The company recognized part of the restructuring gains during the reporting period, positively impacting financial performance [9]. Risk and Uncertainty - The company has not identified any major uncertainties that could affect the accuracy of this earnings forecast [10]. - The preliminary earnings forecast data is subject to final confirmation in the official Q1 2025 report, and investors are advised to be cautious regarding investment risks [11]. - The company’s stock has been warned of delisting risks due to negative net assets and consecutive annual losses from 2021 to 2023 [11].